(Q51866032)

14 April 2018

title

Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer. (English)

1 reference

14 April 2018

0 references

2

M Clemons

1 reference

14 April 2018

author name string

T Skrinskas

1

1 reference

14 April 2018

O Freedman

3

1 reference

14 April 2018

I Weller

4

1 reference

14 April 2018

C M Whyne

5

1 reference

14 April 2018

publication date

22 October 2008

1 reference

14 April 2018

Clinical & Experimental Metastasis

published in

1 reference

14 April 2018

volume

26

1 reference

14 April 2018

issue

2

1 reference

14 April 2018

page(s)

97-103

1 reference

14 April 2018

SECONDARY MALIGNANT DISEASE OF BONE.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10585-008-9219-6

Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions

21 January 2018

1 reference

12 December 2020

The significance of the site of recurrence to subsequent breast cancer survival.

1 reference

12 December 2020

Quantitative characterization of metastatic disease in the spine. Part II. Histogram-based analyses.

1 reference

12 December 2020

Bisphosphonates for breast cancer

1 reference

12 December 2020

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel

1 reference

12 December 2020

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

1 reference

12 December 2020

Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method.

1 reference

12 December 2020

Bioclinical correlations in bony metastases. Results of a prospective study. 60 cases

1 reference

12 December 2020

Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy

1 reference

12 December 2020

Osteolytic bone metastasis in breast cancer

1 reference

12 December 2020

Metastatic bone tumors. Nonsurgical treatment. Outcome and survival

1 reference

12 December 2020

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

12 December 2020

Molecular mechanisms of osteolytic bone metastases

1 reference

12 December 2020

Spinal metastases: the obvious, the occult, and the impostors

1 reference

12 December 2020

Clinical features of metastatic bone disease and risk of skeletal morbidity

1 reference

12 December 2020

Recent developments in bisphosphonates for patients with metastatic breast cancer

1 reference

12 December 2020

Bisphosphonates and breast carcinoma

1 reference

12 December 2020

Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem

1 reference

12 December 2020

CARCINOMATOUS METASTASIS TO THE VERTEBRAL BODIES.

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

12 December 2020

Metastases in carcinoma; analysis of 1000 autopsied cases

1 reference

12 December 2020

10.1007/S10585-008-9219-6

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018